These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%. Grimm W; Hoffmann J Jü; Müller HH; Maisch B J Am Coll Cardiol; 2002 Mar; 39(5):780-7. PubMed ID: 11869841 [TBL] [Abstract][Full Text] [Related]
6. Inappropriate shock delivery by implantable defibrillators with dual chamber pacing during nonsustained ventricular tachycardia in patients with heart block. Sra J; Akhtar M Pacing Clin Electrophysiol; 2000 Jun; 23(6):1054-6. PubMed ID: 10879396 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of a programming algorithm for the third tachycardia zone in a fourth-generation implantable cardioverter-defibrillator. Neglia JJ; Krol RB; Giorgberidze I; Mathew P; Lewis C; Munsif AN; Saksena S J Interv Card Electrophysiol; 1997 Feb; 1(1):49-56. PubMed ID: 9869951 [TBL] [Abstract][Full Text] [Related]
8. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia. Grimm W; Hoffmann J; Menz V; Luck K; Maisch B J Am Coll Cardiol; 1998 Sep; 32(3):739-45. PubMed ID: 9741521 [TBL] [Abstract][Full Text] [Related]
12. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ; J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671 [TBL] [Abstract][Full Text] [Related]
13. Programming of implantable cardioverter-defibrillators on the basis of the upper limit of vulnerability. Swerdlow CD; Peter CT; Kass RM; Gang ES; Mandel WJ; Hwang C; Martin DJ; Chen PS Circulation; 1997 Mar; 95(6):1497-504. PubMed ID: 9118518 [TBL] [Abstract][Full Text] [Related]
14. Results of delivered therapy for VT or VF in patients with third-generation implantable cardioverter defibrillators. Rabinovich R; Muratore C; Iglesias R; Gonzalez M; Serafrica M; Sosa Liprandi A Pacing Clin Electrophysiol; 1995 Jan; 18(1 Pt 2):133-6. PubMed ID: 7724386 [TBL] [Abstract][Full Text] [Related]
15. Extravascular Implantable Cardioverter-Defibrillator Sensing and Detection in a Large Global Population. Swerdlow C; Gillberg J; Boersma LVA; Manlucu J; Zhang X; Zhang Y; Hernandez AA; Bhatia V; Murgatroyd F JACC Clin Electrophysiol; 2024 Aug; 10(8):1896-1912. PubMed ID: 38752961 [TBL] [Abstract][Full Text] [Related]
16. Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications. Link MS; Bockstall K; Weinstock J; Alsheikh-Ali AA; Semsarian C; Estes NAM; Spirito P; Haas TS; Rowin EJ; Maron MS; Maron BJ J Cardiovasc Electrophysiol; 2017 May; 28(5):531-537. PubMed ID: 28240435 [TBL] [Abstract][Full Text] [Related]